Table: Stella Pharma - 9-MTH parent results

Stella Pharma

13/02/2024 06:20

Feb 13 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2023        Dec 31, 2022      Mar 31, 2024  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            200 mln             175 mln           269 mln    
                 (+14.3 pct)        (+106.8 pct)       (+17.4 pct)  
  Operating     loss 466 mln        loss 503 mln      loss 792 mln  
  Recurring     loss 466 mln        loss 480 mln      loss 793 mln  
  Net           loss 469 mln        loss 483 mln      loss 797 mln  
  EPS          loss 15.19 yen      loss 16.85 yen    loss 25.74 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T